269 related articles for article (PubMed ID: 10880015)
1. Studies of direct intratumoral gene transfer using cationic lipid-complexed plasmid DNA.
Clark PR; Stopeck AT; Ferrari M; Parker SE; Hersh EM
Cancer Gene Ther; 2000 Jun; 7(6):853-60. PubMed ID: 10880015
[TBL] [Abstract][Full Text] [Related]
2. Cationic lipid gene transfer of an IL-2 transgene leads to activation of natural killer cells in a SCID mouse human tumor xenograft.
Clark PR; Stopeck AT; Parker SE; Hersh EM
Cell Immunol; 2000 Sep; 204(2):96-104. PubMed ID: 11069717
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy of established tumors in mice by intratumoral injection of interleukin-2 plasmid DNA: induction of CD8+ T-cell immunity.
Saffran DC; Horton HM; Yankauckas MA; Anderson D; Barnhart KM; Abai AM; Hobart P; Manthorpe M; Norman JA; Parker SE
Cancer Gene Ther; 1998; 5(5):321-30. PubMed ID: 9824052
[TBL] [Abstract][Full Text] [Related]
4. [Studies of mouse interleukin-2 gene therapy for head, and neck sequamous cell carcinoma using polycationic liposome-mediated transduction].
Yang H; Liu S; Liang C; Peng W
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jan; 34(1):9-11, 30. PubMed ID: 15600166
[TBL] [Abstract][Full Text] [Related]
5. IL-2 plasmid therapy of murine ovarian carcinoma inhibits the growth of tumor ascites and alters its cytokine profile.
Horton HM; Dorigo O; Hernandez P; Anderson D; Berek JS; Parker SE
J Immunol; 1999 Dec; 163(12):6378-85. PubMed ID: 10586027
[TBL] [Abstract][Full Text] [Related]
6. Plasmid DNA gene therapy: studies with the human interleukin-2 gene in tumor cells in vitro and in the murine B16 melanoma model in vivo.
Parker SE; Khatibi S; Margalith M; Anderson D; Yankauckas M; Gromkowski SH; Latimer T; Lew D; Marquet M; Manthorpe M; Hobart P; Hersh E; Stopeck AT; Norman J
Cancer Gene Ther; 1996; 3(3):175-85. PubMed ID: 8725882
[TBL] [Abstract][Full Text] [Related]
7. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
O'Malley BW; Li D; McQuone SJ; Ralston R
Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
[TBL] [Abstract][Full Text] [Related]
8. In vivo cytokine gene therapy of human tumor xenografts in SCID mice by liposome-mediated DNA delivery.
Egilmez NK; Cuenca R; Yokota SJ; Sorgi F; Bankert RB
Gene Ther; 1996 Jul; 3(7):607-14. PubMed ID: 8818648
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral administration of a 1,2-dimyristyloxypropyl-3- dimethylhydroxyethyl ammonium bromide/dioleoylphosphatidylethanolamine formulation of the human interleukin-2 gene in the treatment of metastatic renal cell carcinoma.
Galanis E; Burch PA; Richardson RL; Lewis B; Pitot HC; Frytak S; Spier C; Akporiaye ET; Peethambaram PP; Kaur JS; Okuno SH; Unni KK; Rubin J
Cancer; 2004 Dec; 101(11):2557-66. PubMed ID: 15517589
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of combined interleukin 2 and B7.1 vaccination strategy is dependent on the sequence and order: a liposome-mediated gene therapy treatment for bladder cancer.
Larchian WA; Horiguchi Y; Nair SK; Fair WR; Heston WD; Gilboa E
Clin Cancer Res; 2000 Jul; 6(7):2913-20. PubMed ID: 10914741
[TBL] [Abstract][Full Text] [Related]
11. Direct gene transfer to mouse melanoma by intratumor injection of free DNA.
Yang JP; Huang L
Gene Ther; 1996 Jun; 3(6):542-8. PubMed ID: 8789804
[TBL] [Abstract][Full Text] [Related]
12. A novel minimal-size vector (MIDGE) improves transgene expression in colon carcinoma cells and avoids transfection of undesired DNA.
Schakowski F; Gorschlüter M; Junghans C; Schroff M; Buttgereit P; Ziske C; Schöttker B; König-Merediz SA; Sauerbruch T; Wittig B; Schmidt-Wolf IG
Mol Ther; 2001 May; 3(5 Pt 1):793-800. PubMed ID: 11356084
[TBL] [Abstract][Full Text] [Related]
13. Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration.
Liu F; Qi H; Huang L; Liu D
Gene Ther; 1997 Jun; 4(6):517-23. PubMed ID: 9231067
[TBL] [Abstract][Full Text] [Related]
14. Optimization of cationic lipid/DNA complexes for systemic gene transfer to tumor lesions.
Anwer K; Kao G; Proctor B; Rolland A; Sullivan S
J Drug Target; 2000; 8(2):125-35. PubMed ID: 10852344
[TBL] [Abstract][Full Text] [Related]
15. Liposomal lipid and plasmid DNA delivery to B16/BL6 tumors after intraperitoneal administration of cationic liposome DNA aggregates.
Reimer DL; Kong S; Monck M; Wyles J; Tam P; Wasan EK; Bally MB
J Pharmacol Exp Ther; 1999 May; 289(2):807-15. PubMed ID: 10215656
[TBL] [Abstract][Full Text] [Related]
16. Serum as a modulator of lipoplex-mediated gene transfection: dependence of amphiphile, cell type and complex stability.
Audouy S; Molema G; de Leij L; Hoekstra D
J Gene Med; 2000; 2(6):465-76. PubMed ID: 11199267
[TBL] [Abstract][Full Text] [Related]
17. Stabilized plasmid-lipid particles for regional gene therapy: formulation and transfection properties.
Zhang YP; Sekirov L; Saravolac EG; Wheeler JJ; Tardi P; Clow K; Leng E; Sun R; Cullis PR; Scherrer P
Gene Ther; 1999 Aug; 6(8):1438-47. PubMed ID: 10467368
[TBL] [Abstract][Full Text] [Related]
18. Effective gene transfer to solid tumors using different nonviral gene delivery techniques: electroporation, liposomes, and integrin-targeted vector.
Cemazar M; Sersa G; Wilson J; Tozer GM; Hart SL; Grosel A; Dachs GU
Cancer Gene Ther; 2002 Apr; 9(4):399-406. PubMed ID: 11960291
[TBL] [Abstract][Full Text] [Related]
19. Intratumoral pharmacokinetics and in vivo gene expression of naked plasmid DNA and its cationic liposome complexes after direct gene transfer.
Nomura T; Nakajima S; Kawabata K; Yamashita F; Takakura Y; Hashida M
Cancer Res; 1997 Jul; 57(13):2681-6. PubMed ID: 9205077
[TBL] [Abstract][Full Text] [Related]
20. Poly(cationic lipid)-mediated in vivo gene delivery to mouse liver.
Liu L; Zern MA; Lizarzaburu ME; Nantz MH; Wu J
Gene Ther; 2003 Jan; 10(2):180-7. PubMed ID: 12571647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
